These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 24223768)

  • 1. Preferential activation of the hedgehog pathway by epigenetic modulations in HPV negative HNSCC identified with meta-pathway analysis.
    Fertig EJ; Markovic A; Danilova LV; Gaykalova DA; Cope L; Chung CH; Ochs MF; Califano JA
    PLoS One; 2013; 8(11):e78127. PubMed ID: 24223768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation regulated microRNAs in HPV-16-induced head and neck squamous cell carcinoma (HNSCC).
    Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M
    Mol Cell Biochem; 2018 Nov; 448(1-2):321-333. PubMed ID: 29455435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of activation of the LIMD1-VHL-HIF1α pathway during head-&-neck squamous cell carcinoma development.
    Mukhopadhyay D; Chakraborty B; Sarkar S; Alam N; Panda CK
    Indian J Med Res; 2024 May; 159(5):479-493. PubMed ID: 39382421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma.
    Gaykalova DA; Manola JB; Ozawa H; Zizkova V; Morton K; Bishop JA; Sharma R; Zhang C; Michailidi C; Considine M; Tan M; Fertig EJ; Hennessey PT; Ahn J; Koch WM; Westra WH; Khan Z; Chung CH; Ochs MF; Califano JA
    Int J Cancer; 2015 Oct; 137(8):1879-89. PubMed ID: 25857630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of gene methylation in human papillomavirus associated-head and neck squamous cell carcinoma.
    Zhang HZ; Shan CG; Huang AP; Wang JM
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of human papillomavirus (HPV) 16 DNA integration and the ensuing patterns of methylation in HPV-associated head and neck squamous cell carcinoma cell lines.
    Hatano T; Sano D; Takahashi H; Hyakusoku H; Isono Y; Shimada S; Sawakuma K; Takada K; Oikawa R; Watanabe Y; Yamamoto H; Itoh F; Myers JN; Oridate N
    Int J Cancer; 2017 Apr; 140(7):1571-1580. PubMed ID: 28006857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Expression and DNA Methylation in Human Papillomavirus Positive and Negative Head and Neck Squamous Cell Carcinomas.
    Hinić S; Rich A; Anayannis NV; Cabarcas-Petroski S; Schramm L; Meneses PI
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
    Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histoepigenetic analysis of HPV- and tobacco-associated head and neck cancer identifies both subtype-specific and common therapeutic targets despite divergent microenvironments.
    Carrero I; Liu HC; Sikora AG; Milosavljevic A
    Oncogene; 2019 May; 38(19):3551-3568. PubMed ID: 30655605
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X
    Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique DNA methylation loci distinguish anatomic site and HPV status in head and neck squamous cell carcinoma.
    Lleras RA; Smith RV; Adrien LR; Schlecht NF; Burk RD; Harris TM; Childs G; Prystowsky MB; Belbin TJ
    Clin Cancer Res; 2013 Oct; 19(19):5444-55. PubMed ID: 23894057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV.
    Walline HM; Carey TE; Goudsmit CM; Bellile EL; D'Souza G; Peterson LA; McHugh JB; Pai SI; Lee JJ; Shin DM; Ferris RL;
    Mol Cancer Res; 2017 Feb; 15(2):179-188. PubMed ID: 27899422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demethylation Therapy as a Targeted Treatment for Human Papillomavirus-Associated Head and Neck Cancer.
    Biktasova A; Hajek M; Sewell A; Gary C; Bellinger G; Deshpande HA; Bhatia A; Burtness B; Judson B; Mehra S; Yarbrough WG; Issaeva N
    Clin Cancer Res; 2017 Dec; 23(23):7276-7287. PubMed ID: 28916527
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of Epigenomic Alterations in HPV16+ Head and Neck Squamous Cell Carcinomas.
    Berglund A; Muenyi C; Siegel EM; Ajidahun A; Eschrich SA; Wong D; Hendrick LE; Putney RM; Kim S; Hayes DN; Shibata D
    Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):858-869. PubMed ID: 35064062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated TRAF3 Fosters Activation of Alternative NF-κB and Reduced Expression of Antiviral Interferon, TP53, and RB to Promote HPV-Positive Head and Neck Cancers.
    Zhang J; Chen T; Yang X; Cheng H; Späth SS; Clavijo PE; Chen J; Silvin C; Issaeva N; Su X; Yarbrough WG; Annunziata CM; Chen Z; Van Waes C
    Cancer Res; 2018 Aug; 78(16):4613-4626. PubMed ID: 29921694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer.
    Lajer CB; Garnæs E; Friis-Hansen L; Norrild B; Therkildsen MH; Glud M; Rossing M; Lajer H; Svane D; Skotte L; Specht L; Buchwald C; Nielsen FC
    Br J Cancer; 2012 Apr; 106(9):1526-34. PubMed ID: 22472886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV
    Brand TM; Hartmann S; Bhola NE; Peyser ND; Li H; Zeng Y; Isaacson Wechsler E; Ranall MV; Bandyopadhyay S; Duvvuri U; LaVallee TM; Jordan RCK; Johnson DE; Grandis JR
    Clin Cancer Res; 2017 Jun; 23(12):3072-3083. PubMed ID: 27986750
    [No Abstract]   [Full Text] [Related]  

  • 19. A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
    Liu C; Guo T; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Califano JA
    Cancer; 2020 Feb; 126(4):737-748. PubMed ID: 31721164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
    Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS
    Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.